Haleon (NYSE:HLN) Stock Rating Lowered by Hsbc Global Res

Haleon (NYSE:HLN) was downgraded by stock analysts at Hsbc Global Res from a “strong-buy” rating to a “hold” rating in a research note issued on Wednesday,Zacks.com reports.

Other equities analysts have also issued research reports about the company. HSBC reaffirmed a “hold” rating on shares of Haleon in a research note on Wednesday. Sanford C. Bernstein lowered shares of Haleon from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 8th. Finally, Morgan Stanley downgraded shares of Haleon from an “overweight” rating to an “equal weight” rating in a report on Friday, January 10th. Five investment analysts have rated the stock with a hold rating, two have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $10.95.

Haleon Trading Down 1.2 %

Haleon stock opened at $10.55 on Wednesday. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. Haleon has a 12-month low of $7.89 and a 12-month high of $10.80. The firm has a market capitalization of $47.74 billion, a price-to-earnings ratio of 31.01, a P/E/G ratio of 2.82 and a beta of 0.28. The firm has a 50 day moving average of $9.63 and a 200 day moving average of $9.85.

Haleon (NYSE:HLN) last announced its quarterly earnings data on Thursday, February 27th. The company reported $0.05 EPS for the quarter. The firm had revenue of $3.54 billion for the quarter, compared to the consensus estimate of $3.38 billion. Haleon had a net margin of 10.85% and a return on equity of 14.76%. As a group, research analysts predict that Haleon will post 0.43 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the business. Sierra Ocean LLC purchased a new stake in shares of Haleon during the 4th quarter valued at about $26,000. Versant Capital Management Inc increased its stake in Haleon by 2,029.1% during the fourth quarter. Versant Capital Management Inc now owns 3,513 shares of the company’s stock worth $34,000 after acquiring an additional 3,348 shares during the last quarter. Toronto Dominion Bank raised its position in Haleon by 3,470.0% during the third quarter. Toronto Dominion Bank now owns 3,570 shares of the company’s stock valued at $38,000 after purchasing an additional 3,470 shares during the period. Geneos Wealth Management Inc. bought a new stake in shares of Haleon in the 4th quarter valued at approximately $35,000. Finally, FIL Ltd boosted its holdings in shares of Haleon by 45.7% in the 4th quarter. FIL Ltd now owns 4,049 shares of the company’s stock worth $39,000 after purchasing an additional 1,270 shares during the period. 6.67% of the stock is owned by hedge funds and other institutional investors.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.